{
  "id": "05b94106dc6fff6d",
  "title": "STAT+: Pharmalittle: We\u2019re reading about a Roche obesity drug, a clash over 340B claims data, and more",
  "description": "Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial",
  "content": "Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/27/roche-obesity-menopause-china-lilly-340b-hospitals-bausch/?utm_campaign=rss",
  "published_at": "2026-01-27T14:17:23+00:00",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about a Roche obesity drug, a clash over 340B claims data, and more",
    "description": "Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial",
    "url": "https://www.statnews.com/pharmalot/2026/01/27/roche-obesity-menopause-china-lilly-340b-hospitals-bausch/?utm_campaign=rss",
    "published": "2026-01-27T14:17:23+00:00",
    "source": "STAT"
  }
}